QT
EVH icon

Quantamental Technologies’s Evolent Health EVH Stock Holding History

Quantamental Technologies’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11,175
Closed -$139K – 156
2020
Q3 		$139K Buy
+11,175
New +$131K 0.1% 237

Other funds holding EVH

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Quantamental Technologies's EVH Position: Q4 2020 in Review

Quantamental Technologies sold out of Evolent Health (EVH) in Q4 2020, closing a stake of 11,175 shares — an estimated $139K sold.

Quantamental Technologies first reported a position in EVH in Q3 2020 and held it in 1 quarter. The position peaked at $139K in Q3 2020. 161 funds tracked by Wall St. Rank hold EVH as of Q4 2020.

  • Quantamental Technologies reported no remaining Evolent Health position as of Q4 2020 after selling out during the quarter.
  • Quantamental Technologies sold 11,175 Evolent Health shares in Q4 2020, an estimated $139K.
  • Quantamental Technologies first reported a position in Evolent Health in Q3 2020 and held it in 1 quarter.
  • Quantamental Technologies's Evolent Health position peaked at $139K in Q3 2020.
  • 161 funds tracked by Wall St. Rank held Evolent Health as of Q4 2020.

Based on Quantamental Technologies's 13F filing for Q4 2020, filed 16 Feb 2021.